U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07068282) titled 'The Effect of Novel D3 Use as a Mouthwash in COVID-19 Patients' on June 24.
Brief Summary: The PI's goal of this [interventional/clinical trial] is to [explore the antiviral properties of vitamin D3 on saliva samples collected before and after the use of a vitamin D3 mouthwash] in [ adult participants, both genders, with COVID-19 who tested positive on a swab test]. The main question[s] aims to answer [is]:
[Assess the antiviral potential of a novel vitamin D-based mouthwash in COVID-19-positive participants].
PI will compare both [Control group: saliva only- before use of mouthwash], and the [study group: after use of the mouthwa...